Boehringer Ingelheim's R&D expenditure as a percentage of revenue 2004-2018

Boehringer Ingelheim's expenditure on research and development as a percentage of revenue from 2004 to 2018

by Matej Mikulic, last edited Apr 25, 2019
Boehringer Ingelheim's R&D expenditure as a percentage of revenue 2004-2018 This statistic shows Boehringer Ingelheim's expenditure on research and development as a percentage of revenues between 2004 and 2018. In 2018, 18.1 percent of the company's total revenues were issued on research and development. The Boehringer Ingelheim group is one of the world's top 20 pharmaceutical companies. The company is headquartered in Ingelheim, Germany.
Show more

Boehringer Ingelheim's expenditure on research and development as a percentage of revenue from 2004 to 2018

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Pharmaceutical trends in Europe"
  • Overview
The most important statistics
  • European Pharmaceutical companies
  • Self-medication market
  • Employment
  • Clinical Trials
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.